The Reflection of Quality
An integrated healthcare system, built through science, disciplined processes, and trusted delivery.
For further information on partnership and business opportunities, please contact: info@dexagroup.com
Insights & Perspectives
3 November 2025
Dexa Medica Contributes to Supporting the Health Minister’s Target of 70 Million Indonesians Receiving Free Health Screenings by 2025
Minister of Health Budi Gunadi Sadikin has set a target for 60–70 million Indonesians to receive free health screenings by 2025. In support of this initiative, PT Dexa Medica continues to contribute through its Cek Segitiga Gratis program, which recently took place at the Car Free Day area on Boulevard Makassar, Sunday, October 26, 2025. The event received an enthusiastic response from Makassar residents, with more than 400 participants taking part in free checks for blood pressure,...
27 October 2025
WHO and BPOM Recognize DLBS Phytopharmaceutical Innovation as a Global Benchmark in Green Pharmacy
A delegation from the World Health Organization (WHO) and Indonesia’s National Agency for Drug and Food Control (BPOM RI) visited Dexa Laboratories of Biomolecular Sciences (DLBS) to observe firsthand how Indonesia’s biodiversity is being utilized in pharmaceutical research for the development of Modern Indonesian Natural Medicine (OMAI). Prof. Raymond Tjandrawinata, Director of Business Development and Scientific Affairs at PT Dexa Medica, shared the journey of DLBS in developing...
16 October 2025
30,000 Medicinal Plants, Only 20 Phytopharmaceuticals: Dexa Medica Strengthens Indonesia’s Role at the 16th WHO–IRCH Global Forum
Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for Herbal Medicines (IRCH), held at JS Luwansa Hotel and Convention Center, Jakarta, on Tuesday, October 14,...
2 October 2025
More Than 1,500 Residents Join Dexa Medica’s Free Health Check, Reinforcing Commitment to Quality and Halal Medicine Access
Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga initiative, once again provided free health checks for the public, this time at Bintaro Xchange Mall, South Tangerang, on Saturday, September 27, 2025. The...
2 October 2025
Dexa Group Receives Two Prestigious Awards in One Day for Its Commitment to Halal Assurance Across All Products and Facilities
Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies (LPH LPPOM), both official institutions for halal certification. The first recognition was the Indonesia Halal Industry Awards (IHYA) 2025 from the...
- Page 2
Recognition
Dexa Group's commitment to delivering nationally and globally standardized quality is demonstrated through its tangible contributions to public health and the pharmaceutical industry. From developing research-based innovations and strengthening national healthcare independence to fulfilling therapeutic needs for millions of chronic disease patients and expanding products into international markets, Dexa continues to reinforce its role as a healthcare company that creates meaningful impact. This consistency has earned recognition and appreciation from regulatory authorities, government institutions, national media, and international organizations — reflecting Dexa's strong track record in quality, innovation, export leadership, integrity, and trusted corporate governance.
Certified Facilities
Dexa Medica
Palembang
Core legacy manufacturing — broad-volume pharmaceutical output.
Core Specializations:
Oral solid non-Cephalosporine (tablet, caplet, hard gelatin capsule, dry syrup) & Cephalosporine (tablet, hard gelatin capsule, dry syrup, dry powder injection).
Certifications:
Dexa Medica
Cikarang
API and specialty manufacturing; Industry 4.0 implementation hub.
Core Specializations:
Natural Extract Active Pharmaceutical Ingredients, Protein Extracts, Oral Solid Dosage Forms.
Certifications:
Ferron Par Pharmaceuticals
Cikarang
Regulated-market export platform — UK-MHRA certified oral solid facility.
Core Specializations:
Solids, liquids, semi-solids, sterile injectables, eye drops, API bulk lyo.
Certifications:
Beta Pharmacon
Karawang
High-volume, efficiency-oriented access manufacturing.
Core Specializations:
Tablets, soft capsule, soft-gels.
Certifications:
Fonko International Pharmaceuticals
Cikarang
Specialized oncology manufacturing — EU-GMP certified.
Core Specializations:
Oncology small volume injection, Oncology freeze dry injection, Oncology tablet, Oncology hard capsule.
Certifications:
Dexa Laboratories of Biomolecular Sciences (DLBS)
Cikarang
Integrative Natural-Modern Medicine (OMAI) Research Center — Including Stimuno® (Phytopharmaceutical) and HerbaKOF® (Standardized Herbal Medicine).
Core Specializations:
Research and Development of Integrative Natural-Modern Medicine (OMAI).
Certifications:
Anugrah Amartha Global
Bogor
OMAI & high-value product manufacturing platform.
Core Specializations:
Oral Solid Dosage Forms, Semi-Solid, Natural Oral Liquid, Natural Supplements and Softgels, and Bioactive Natural Fractions for API Development.
Certifications:
Dexa Development Center
Cikarang
The Dexa Development Center serves as the Dexa Group's innovation and new product development hub.
Core Specializations:
Focusing on first off-patent generics, complex generics (formulations, dosage forms, etc) and new drug delivery systems.
Certifications:
Public Trust Snapshot
Through the Dexa Quality Campaign Survey, thousands of respondents expressed strong confidence in Dexa Group. With an overall score of 4.92 out of 5, the result reflects that Dexa's quality is not only embedded in its products, but has become an integral part of the company's identity — built upon science, integrity, and global standards. From research and high-precision manufacturing processes to a safeguarded distribution system and recognition from both national and international regulatory bodies such as EU-GMP, Dexa Group consistently delivers trusted and reliable quality. This trust continues to live on among Indonesian families and serves as the foundation for Dexa's journey as a respected global healthcare company.
QUALITY RATING
4.92
FROM 5
Participants Demographic
33 Provinces
in Indonesia
End-to-end Quality Implementation
Research & Innovation
Dexa Group develops science-based healthcare innovations through the Dexa Development Center (DDC) and the Dexa Laboratories of Biomolecular Sciences (DLBS). Research activities span first off-patent generics, complex generics (formulations, dosage forms, and related developments), new drug delivery systems, and Integrative Modern Natural Medicines in the form of phytopharmaceuticals and standardized herbal medicines derived from Indonesia's biodiversity. Supported by multidisciplinary researchers and continuous R&D investment, Dexa Group transforms research into validated healthcare solutions relevant to international markets.
Globally Aligned Manufacturing
Dexa Group operates manufacturing facilities that comply with national and international standards, including EU-GMP, supported by modern technology and rigorous quality control systems. Selected facilities have obtained international certifications and regulatory recognitions, including from authorities in Indonesia, the United Kingdom, Qatar, Zimbabwe, Tanzania, Hungary, and Portugal. Each facility is designed to ensure precision, consistency, and reliability of quality across global markets.
Halal Integrity
Dexa Group's commitment to quality extends through halal integrity, maintained from raw material sourcing and production to distribution. This system ensures that products reaching patients and consumers meet halal standards applicable in Indonesia, while strengthening public trust in the healthcare solutions we deliver.
Integrated Distribution Network
Dexa Group maintains product accessibility through an integrated distribution system serving healthcare facilities, pharmacies, and institutional partners across Indonesia and export markets. The distribution network is designed to safeguard product integrity, availability, traceability, and delivery reliability, ensuring healthcare solutions reach patients with consistent quality throughout the supply chain.
Compliance & Quality Systems
Dexa Group implements an integrated Quality Management System (QMS) across all of its business units. The system is supported by quantitative assessments through quality metrics, operational KPIs, and Pharmaceutical Industry Maturity Assessments aligned with the standards of the Indonesian Food and Drug Authority (BPOM RI), as well as internally developed frameworks that refer to the Pharmaceutical Quality System (PQS) under ICH Q10 and the International Society for Pharmaceutical Engineering (ISPE) standards. Quality is embedded at every stage of the product lifecycle, from development and technology transfer to commercial manufacturing and post-marketing monitoring.
Our Commitment
Dexa Group operates an end-to-end quality system designed to ensure consistency, compliance, and reliability across the healthcare value chain. This commitment is reflected through science-based innovation, disciplined manufacturing processes, integrated distribution systems, compliance with national and international regulations, halal integrity, and continuous operational improvement. Through these systems, Dexa Group delivers healthcare solutions that remain trusted by healthcare professionals, institutions, and communities.
Quality Beyond Products
At Dexa Group, quality extends beyond the final product. It is built into every stage of the healthcare journey, from scientific discovery and product development to manufacturing systems, supply chain integrity, and patient access. This philosophy has shaped Dexa Group since its establishment in 1969 under one enduring principle: Quality Above All. Supported by continuous investment in research and development, integrated operational systems, and manufacturing standards aligned with international regulations, Dexa Group continues to strengthen its role as a trusted healthcare partner in Indonesia and global markets.
Since 1969, Dexa Group has built healthcare capabilities that connect research, manufacturing, distribution, and patient access into one integrated system. Across discovery, regulatory compliance, manufacturing precision, and nationwide distribution, every process is designed to ensure consistency, reliability, and long-term trust. The principle of "Quality Above All" guides these capabilities across Indonesia and international markets.